FIELD: pharmacology.
SUBSTANCE: compounds of this invention reduce the expression level of CXCL-1, TNF-α or MIP-2, and thus do not have the side effects of the currently used therapeutic agents for chronic obstructive pulmonary disease treatment, are non-toxic and have an excellent therapeutic effect, so that they can be useful as a composition for prevention, treatment and reduction of chronic obstructive pulmonary diseaseseverity.
EFFECT: prevention of chronic obstructive pulmonary disease containing monoacetyl diacylglycerin as an active ingredient.
10 cl, 6 ex, 8 tbl
| Title |
Year |
Author |
Number |
| COMPOSITION FOR ASTHMA PREVENTION OR TREATMENT CONTAINING MONOACETHYLDIACYL GLYCERINE COMPOUND AS ACTIVE INGREDIENT |
2014 |
- O Sej-Ryan
- An Kyun Sop
- Li Su Ui
- Sin In Sik
- Sin Na-Ne
- Li Te-Sok
- Kan Chonko
- Chon Yun-Sik
- Khan En-Khe
- Son Ki En
|
RU2636615C2 |
| COMPOSITION FOR DETECTION OF CANCER BLOOD DISEASES OR METASTASIS OF CANCER CONTAINING ACTIVE INGREDIENT MONOACETHYL DIGLYCERIDE COMPOUND |
2014 |
- Kim Che Khva
- O Sej Ryan
- An Kyun Sop
- Kan Kho Pum
- Sin Che Min
- Ko Yun Yn
- Li Te Sok
- Kim Men Khvan
- Kan Chon Ko
- Khan En-Khe
- Son Ki-Yun
|
RU2632098C2 |
| COMPOSITIONS CONTAINING MONOACETYLDIACYLGLYCERIDE AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING RHEUMATOID ARTHRITIS |
2014 |
- Kim Che Khva
- O Sej Ryan
- An Kyun Sop
- Kan Kho Pum
- Pek Pom Su
- Li Te-Sok
- Kan Chon Ko
- Chon Yun-Sik
- Khan En-Khe
- Son Ki En
|
RU2646823C2 |
| COMPOSITION FOR ATOPIC ECZEMA PREVENTION OR TREATMENT CONTAINING MONOACETYLDIACYL GLYCERINE COMPOUND AS ACTIVE INGREDIENT |
2014 |
- Kim Che Khva
- O Sej-Ryan
- An Kyun Sop
- Kan Kho Pum
- Yu Che Mine
- Li Te-Sok
- Kan Chonko
- Kim Khe Kyun
- Yuk Chin Su
- Khan En-Khe
- Son Ki En
|
RU2640503C2 |
| METHODS OF TREATING LEUKOPENIA AND THROMBOCYTOPENIA |
2015 |
- Khan En-Khe
- Chon Sekho
- Son Ki-Yun
- Kim Men-Khvan
- Kim Che Khva
|
RU2702122C2 |
| IMMUNOMODULATORY AGENT, CANCER AGENT AND HEALTHY FOOD CONTAINING MONOACETYLDIACYLGLYCERIN DERIVATIVES |
2005 |
|
RU2341257C2 |
| COMPOSITION CONTAINING PURIFIED EXTRACT, EXTRACTED FROM Pseudolysimachion rotundum var.subintegrum CONTAINING GREAT AMOUNT OF ACTIVE COMPONENT,OR COMPOUNDS, EXTRACTED FROM IT, AS ACTIVE COMPONENT FOR PROPHYLAXIS OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND THEREOF |
2014 |
- Li Ennam
- Yu Chi-Sok
- Sin Te-Khi
- Lyu Pen-Khvan
- An Ken Sop
- O Se Lyan
- Li Khen Ke
- Sin In Sik
- Kim Du En
- Kvon Ok-Ken
- Son Khek Khvan
- Kim Syn Khen
- Li Suuj
|
RU2594061C1 |
| NEW COMPOUND ISOLATED FROM PSEUDOLYSIMACHION ROTUNDUM VAR. SUBINTEGRUM, WITH A HIGH CONTENT OF ACTIVE INGREDIENT, COMPOSITION CONTAINING SAID COMPOUND FOR PREVENTING OR TREATING ALLERGIC DISEASE, INFLAMMATORY DISEASE, ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND USE THEREOF |
2015 |
- Li Ennam
- Yu Chi-Sok
- Sin Te-Khi
- Yu Pen-Khvan
- O Si-Yan
- An Ken-Sop
- Li Khen-Ke
- Li Su Uj
- Son Khek-Khvan
- Sin In-Sik
- Yu Khen Von
|
RU2685732C2 |
| MEDICATION, CONTAINING FGF2 AS ACTIVE INGREDIENT, FOR TREATMENT OR PREVENTION OF ASTHMA AND CHRONIC OBSTRUCTIVE LUNG DISEASES |
2005 |
- Kim Joon-Keun
- Kang Soo Khiung
- Kim Biong Moon
- Son Mivon
|
RU2351356C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ATTENUATED Streptococcus pneumoniae STRAINS, AND ITS APPLICATION |
2018 |
- Rhee, Dong-Kwon
- Seon, Seung-Han
- Kim, Bo-Gyung
|
RU2772131C2 |
